AN-019
AN-019 (NRC-019) is a research compound that inhibits the Bcr-Abl kinase, making it a candidate for studying chronic myelogenous leukemia (CML) and breast cancer. Its activity has been investigated in cellular assays and animal models to evaluate its potential therapeutic effects.
Product Specifications
CAS Number
879507-25-2
Product Name Alternative
AN019, AN-019, AN 019, Bcr-Abl, BcrAbl, NRC 019, NRC, NRC-AN 019, NRC-AN019, NRC-AN-019, NRC019, NRC-019
Field of Research
Cardiovascular Research, Signal Transduction
Purity
98.01% (May vary between batches)
Smiles
O=C (NC1=CC=C (C (=C1) NC=2N=CC=C (N2) C3=CN=CC=C3) C) C=4C=C (C=C (C4) C (F) (F) F) C (F) (F) F
Molecular Formula
C25H17F6N5O
Molecular Weight
517.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![2- (tert-Butoxycarbonyl) -5-thia-2-azaspiro[3.4]octane-8-carboxylic acid 5,5-dioxide](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
QDC48181-01 50 mg
2- (tert-Butoxycarbonyl) -5-thia-2-azaspiro[3.4]octane-8-carboxylic acid 5,5-dioxide
Sign In for Pricing
View Details QDC48181-02 0.5 g
2- (tert-Butoxycarbonyl) -5-thia-2-azaspiro[3.4]octane-8-carboxylic acid 5,5-dioxide
Sign In for Pricing
View Details 